Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets

Transplant Immunology

Volumn 22, Issue 1-2, 2009, Pages 55-61

  Lu, Xiaoxi ^a   Liu, Ting ^a   Gu, Ling ^a   Huang, Chunlan ^a   Zhu, Huanling ^a   Meng, Wentong ^a   Xi, Yaming ^a   Li, Shengfu ^a   Liu, Yongmei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Graft versus host disease; Haploidentical bone marrow transplantation; Mesenchymal stem cells; T cell subsets

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTIC INFILTRATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; WHOLE BODY RADIATION;

ANIMALS; BLOOD CELL COUNT; BONE MARROW; BONE MARROW TRANSPLANTATION; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; INTESTINE, SMALL; KAPLAN-MEIERS ESTIMATE; LIVER; LYMPHOCYTE TRANSFUSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CXCR3; SKIN; SPLEEN; TH1 CELLS; TH2 CELLS; WHOLE-BODY IRRADIATION;

EID: 70449530607     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.08.002     Document Type: Article

References (28)

1. Krenger W., Hill G.R., and Ferrara J.L. Cytokine cascades in acute graft-vs.-host disease. Transplantation 64 4 (1997) 553-558
2. Krenger W., Cooke K.R., Crawford J.M., Sonis S.T., Simmons R., Pan L., et al. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease. Transplantation 62 9 (1996) 1278-1285
3. Guo H., Qiao Z., Zhu L., Wang H., Su L., Lu Y., et al. Th1/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation. Am J Hematol 75 2 (2004) 78-83
4. Kataoka Y., Iwasaki T., Kuroiwa T., Seto Y., Iwata N., Hashimoto N., et al. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease. Immunology 103 3 (2001) 310-318
5. Weng Y., Siciliano S.J., Waldburger K.E., Sirotina-Meisher A., Staruch M.J., Daugherty B.L., et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 273 29 (1998) 18288-18291
6. Jaksch M., Remberger M., and Mattsson J. Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 11 4 (2005) 280-287
7. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
8. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 10 (2002) 3838-3843
9. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., and Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 3 (2003) 389-397
10. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., and Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 1 (2003) 11-20
11. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30 1 (2002) 42-48
12. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 9419 (2004) 1439-1441
13. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371 9624 (2008) 1579-1586
14. von Bonin M., Stölzel F., Goedecke A., Richter K., Wuschek N., Hölig K., et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant 43 3 (2009) 245-251
15. Cooke K.R., Kobzik L., Martin T.R., Brewer J., Delmonte Jr. J., Crawford J.M., et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: the roles of minor H antigens and endotoxin. Blood 88 8 (1996) 3230-3239
16. + T cells from rat spleen. J Immunol Methods 244 1-2 (2000) 29-40
17. Tivol E., Komorowski R., and Drobyski W.R. Emergent autoimmunity in graft-versus-host disease. Blood 105 12 (2005) 4885-4891
18. Ringdén O., Uzunel M., Sundberg B., Lönnies L., Nava S., Gustafsson J., et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 21 11 (2007) 2271-2276
19. Van den Brink M.R., and Burakoff S.J. Cytolytic pathways in heamatopoietic stem cell transplantation. Nat Rev Immunol 2 4 (2002) 273-281
20. Belperio J.A., Keane M.P., Arenberg D.A., Addison C.L., Ehlert J.E., Burdick M.D., et al. CXC chemokines in angiogenesis. J Leukoc Biol 68 1 (2000) 1-8
21. Youn B.S., Mantel C., and Broxmeyer H.E. Chemokines, chemokine receptors and hematopoiesis. Immunol Rev 177 (2000) 150-174
22. Luther S.A., and Cyster J.G. Chemokines as regulators of T cell differentiation. Nat Immunol 2 2 (2001) 102-107
23. Piali L., Weber C., LaRosa G., Mackay C.R., Springer T.A., Clark-Lewis I., et al. The chemokine receptor CXCR3 mediates a rapid and shear-resistant adhesion of effector T lymphocytes by the chemokines IP-10 and Mig. Eur J Immunol 28 3 (1998) 961-972
24. Duffner U., Lu B., Hildebrandt G.C., Teshima T., Williams D.L., Reddy P., et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol 31 10 (2003) 897-902
25. Hildebrandt G.C., Corrion L.A., Olkiewicz K.M., Lu B., Lowler K., Duffner U.A., et al. Blockade of CXCR3 receptor: ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome. J Immunol 173 3 (2004) 2050-2059
26. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., et al. Differential expression of chemokin receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187 1 (1998) 129-134
27. Kim C.H., Rott L., Kunkel E.J., Genovese M.C., Andrew D.P., Wu L., et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 108 9 (2001) 1331-1339
28. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., et al. Human mesenchymal stem cells modulate B-cell functions. Blood 107 1 (2006) 367-372